Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Table of Contents

PreviousNext

April 01 1998; volume 47 issue 4

  • You have accessRestricted Access
    PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
    B M Spiegelman
    Diabetes 1998 Apr; 47 (4): 507-514. https://doi.org/10.2337/diabetes.47.4.507
    Add to Selected Citations
  • You have accessRestricted Access
    Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
    L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
    Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
    Add to Selected Citations
  • You have accessRestricted Access
    Basal hepatic glucose production is regulated by the portal vein insulin concentration.
    D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
    Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
    Add to Selected Citations
  • You have accessRestricted Access
    Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
    M Tang-Christensen, N Vrang and P J Larsen
    Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530
    Add to Selected Citations
  • You have accessRestricted Access
    Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
    D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
    Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
    Add to Selected Citations
  • You have accessRestricted Access
    Physiological insulinemia acutely modulates plasma leptin.
    M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
    Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
    Add to Selected Citations
  • You have accessRestricted Access
    Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
    K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
    Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
    Add to Selected Citations
  • You have accessRestricted Access
    Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
    C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
    Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
    Add to Selected Citations
  • You have accessRestricted Access
    The relationship between humoral and cellular immunity to IA-2 in IDDM.
    T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
    Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
    Add to Selected Citations
  • You have accessRestricted Access
    The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    L Liang, E Beshay and G J Prud'homme
    Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570
    Add to Selected Citations
  • You have accessRestricted Access
    Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
    H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
    Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
    Add to Selected Citations
  • You have accessRestricted Access
    Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
    Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
    Add to Selected Citations
  • You have accessRestricted Access
    GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    J Dittler, D Seidel, M Schenker and A G Ziegler
    Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
    Add to Selected Citations
  • You have accessRestricted Access
    Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
    Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
    Add to Selected Citations
  • You have accessRestricted Access
    Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
    E D Kilpatrick and R P Robertson
    Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606
    Add to Selected Citations
  • You have accessRestricted Access
    Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
    G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
    Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
    Add to Selected Citations
  • You have accessRestricted Access
    Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
    K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
    Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
    Add to Selected Citations
  • You have accessRestricted Access
    Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
    Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
    Add to Selected Citations
  • You have accessRestricted Access
    Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
    S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
    Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
    Add to Selected Citations
  • You have accessRestricted Access
    Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
    Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
    Add to Selected Citations
  • You have accessRestricted Access
    Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
    S Higashi, A C Clermont, V Dhir and S E Bursell
    Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653
    Add to Selected Citations
  • You have accessRestricted Access
    Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
    C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
    Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
    Add to Selected Citations
  • You have accessRestricted Access
    Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
    T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
    Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668
    Add to Selected Citations
  • You have accessRestricted Access
    Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
    P Wentzel and U J Eriksson
    Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677
    Add to Selected Citations
  • You have accessRestricted Access
    Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
    G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
    Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
    Add to Selected Citations
  • You have accessRestricted Access
    Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
    G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
    Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
    Add to Selected Citations
  • You have accessRestricted Access
    BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
    S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
    Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
    Add to Selected Citations
Back to top
PreviousNext

In this Issue

April 1998, 47(4)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
  • Most Read
  • Most Cited
Loading
  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
  • Latent Autoimmune Diabetes in Adults
  • Poverty and Obesity in the U.S.
  • The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
  • A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels
More...

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.